These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8677322)

  • 41. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.
    Salzmann P; Kerlikowske K; Phillips K
    Ann Intern Med; 1997 Dec; 127(11):955-65. PubMed ID: 9412300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years.
    Frisell J; Lidbrink E
    J Natl Cancer Inst Monogr; 1997; (22):49-51. PubMed ID: 9709275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiation risk from screening mammography of women aged 40-49 years.
    Feig SA; Hendrick RE
    J Natl Cancer Inst Monogr; 1997; (22):119-24. PubMed ID: 9709287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mammography screening as early detection measure. Pro].
    Koch MG
    Arch Gynecol Obstet; 1996; 259 Suppl 1():S161-77. PubMed ID: 9133270
    [No Abstract]   [Full Text] [Related]  

  • 46. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
    Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mammography--early detection--insurance coverage as IGeL service?].
    Wigge P
    Rofo; 2003 May; 175(5):608-12. PubMed ID: 12816079
    [No Abstract]   [Full Text] [Related]  

  • 48. After 40 years, mammography remains as much emotion as science.
    Randal J
    J Natl Cancer Inst; 2000 Oct; 92(20):1630-2. PubMed ID: 11036103
    [No Abstract]   [Full Text] [Related]  

  • 49. Cost-effectiveness of mammography for older women.
    Finucane TE
    Ann Intern Med; 2004 May; 140(10):844; author reply 844. PubMed ID: 15148077
    [No Abstract]   [Full Text] [Related]  

  • 50. Counting the costs of mammography screening: first year results from the Sydney study.
    Gerard K; Salkeld G; Hall J
    Med J Aust; 1990 May; 152(9):466, 469-71. PubMed ID: 2381337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of alternative practices on the cost and quality of mammographic screening in the United States.
    Burnside E; Belkora J; Esserman L
    Clin Breast Cancer; 2001 Jul; 2(2):145-52. PubMed ID: 11899786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The relationship between health gain and effort in mass screening for breast cancer].
    van Dongen JA; Coebergh JW; de Koning HJ
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2277-80. PubMed ID: 9550810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induced costs of low-cost screening mammography.
    Cyrlak D
    Radiology; 1988 Sep; 168(3):661-3. PubMed ID: 3406395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening.
    Wang H; Kåresen R; Hervik A; Thoresen SO
    Cancer Causes Control; 2001 Jan; 12(1):39-45. PubMed ID: 11227924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of mammographic screening in Australia.
    Carter R; Glasziou P; van Oortmarssen G; de Koning H; Stevenson C; Salkeld G; Boer R
    Aust J Public Health; 1993 Mar; 17(1):42-50. PubMed ID: 8357894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Setting calculations aside.
    Meyer CR
    Minn Med; 2003 Dec; 86(12):2. PubMed ID: 14719607
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cancer of the breast: mass screening by mammography is not justified].
    Colin C
    Rev Med Liege; 1998 Apr; 53(4):212-3. PubMed ID: 9641016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-cost mass screening as a means of reducing overall mortality from breast cancer.
    McLelland R
    Recent Results Cancer Res; 1990; 119():53-9. PubMed ID: 2236862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.